RAFAEL
ENRÍQUEZ DE SALAMANCA LORENTE
Chercheur dans le période 2009-2014
Hospital Universitario 12 de Octubre
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario 12 de Octubre (30)
2023
-
Diagnosis, evaluation and monitoring of acute hepatic porphyria
Medicina Clinica
-
Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria
International Journal of Molecular Sciences, Vol. 24, Núm. 1
2021
-
Acute intermittent porphyria, givosiran, and homocysteine
Journal of Inherited Metabolic Disease
2017
-
Prognostic models for locally advanced cervical cancer: External validation of the published models
Journal of Gynecologic Oncology, Vol. 28, Núm. 5
2015
-
Vitamin D-binding protein as a biomarker of active disease in acute intermittent porphyria
Journal of Proteomics, Vol. 127, pp. 377-385
2014
-
A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro
American Journal of Hematology, Vol. 89, Núm. 7, pp. 689-694
2013
2012
-
Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis
Gene, Vol. 508, Núm. 1, pp. 15-20
2011
-
Tumour VEGF/Non Tumour VEGF protein expression ratio as a biomarker for survival in colorectal cancer patients
European Journal of Surgical Oncology, Vol. 37, Núm. 6, pp. 526-531
-
Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man
European Journal of Haematology, Vol. 86, Núm. 3, pp. 260-264
2010
-
Hepcidin treatment in Hfe-/- mice diminishes plasma iron without affecting erythropoiesis
European Journal of Clinical Investigation, Vol. 40, Núm. 6, pp. 511-517
2009
-
Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: Potential novel players in the progression of liver injury
Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 29-37
-
Identification and characterization of HMBS gene mutations in Spanish patients with acute intermittent porphyria
Cellular and Molecular Biology, Vol. 55, Núm. 2, pp. 55-63
-
In vivo effect an luteinizing hormone-releasing hormone analog on vascular endothelial growth factor and epidermal growth factor receptor expression in mammary tumors
Journal of Carcinogenesis, Vol. 8
-
Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria
Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 38-44
-
Mutation in CNR1 gene and VEGF expression in esophageal cancer
Tumori, Vol. 95, Núm. 1, pp. 68-75
-
Single nucleotide change in the cannabinoid receptor-1 (CNR1) gene in colorectal cancer outcome
Oncology, Vol. 76, Núm. 6, pp. 435-441
2003
-
Colorectal cancer relapse: Allelic alterations associated with tumour marker overexpression
Oncology, Vol. 65, Núm. 2, pp. 146-151
2000
-
Lipoprotein abnormalities in patients with asymptomatic acute porphyria
Clinica Chimica Acta, Vol. 294, Núm. 1-2, pp. 37-43
-
Serum levels of coenzyme Q10 in patients with Alzheimer's disease
Journal of Neural Transmission, Vol. 107, Núm. 2, pp. 233-239